Online inquiry

IVTScrip™ mRNA-Human ATIC, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23365MR)

This product GTTS-WK23365MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATIC protein. This product can be used in Mitotic fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_004044.7
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 471
UniProt ID P31939
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATIC, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23365MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK7725MR IVTScrip™ mRNA-Human ADCYAP1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADCYAP1
GTTS-WK13348MR IVTScrip™ mRNA-Human ACSL4, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ACSL4
GTTS-WK26997MR IVTScrip™ mRNA-Human ATP5D, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATP5D
GTTS-WK22755MR IVTScrip™ mRNA-Human ATG14, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ATG14
GTTS-WK18190MR IVTScrip™ mRNA-Human ANKIB1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ANKIB1
GTTS-WK17290MR IVTScrip™ mRNA-Human ANKIB1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKIB1
GTTS-WK10722MR IVTScrip™ mRNA-Human ADCY7, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADCY7
GTTS-WK0430MR IVTScrip™ mRNA-Human Carboxypeptidase M, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Carboxypeptidase M
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW